Development and content validation of the Symptoms Evolution of COVID-19: a patient-reported electronic daily diary in clinical and real-world studies

Journal of Patient-Reported Outcomes

Table 1 Overview of patient sample characteristics

	N = 30
Age (years), mean (SD)	45.03 (19.39)
Gender, n (%)
Male	12 (40)
Female	18 (60)
Race, n (%)
White	26 (86.7)
Other	4 (13.3)
Education level, n (%)
Secondary	15 (50)
National vocational or work-related qualification	1 (3)
Degree or higher	14 (47)
Number of days between diagnosis and interview, mean (SD)	12.40 (5.29)
Number of days since symptoms began, mean (SD)	19.17 (7.96)
Number of days between symptoms began and diagnosis, mean (SD)	6.77 (7.96)
General health ratings, n (%)
Excellent	6 (20)
Very good	8 (26.7)
Good	4 (13.3)
Fair	9 (30)
Poor	3 (10)
Comorbidities^a, n (%)	17 (57)

^aComorbidities across sample include: cardiovascular disease (e.g., heart failure, coronary artery disease, cardiomyopathy, pulmonary hypertension, pulmonary fibrosis), hypertension, diabetes (e.g., type 1, type 2, gestational), chronic obstructive pulmonary disease, chronic kidney disease, cancer, stickle cell disease, metabolic dysfunction-associated fatty liver disease, chronic liver disease (e.g., cirrhosis), history of stroke, thalassemia